Morning Van and Stoney, is the NRSN ALS news huge? I use to donate time driving patients 200-300 miles each direction to USCF and UCLA getting medical treatment for a disease with no treatment.
GBA Presents: THE BARE ESSENTIALS
- Thread starter stonedinvestor
- Start date
DBI >>> +.6%
SCVL>>> - 2.7%
Does SCVL have these?
Ask Mrs Stoney if that's a good price.
https://www.bottegaveneta.com/en-ca...efn3=countryInclusion&prefv3=CA&start=0&sz=36
Last edited:
If it works it is.
Up 295%.
I remember clinical trials using Celebrex during its debacle almost twenty years ago, it looks like the Cox inhibitors are part of the drug. Risky because ALS is so dam hard to treat, I bought some from $4-$6, looking to get $8+ but there's so many icebergs dumping at $6.1-$6.8.
BROS looks to want to squeeze some more. $58 might be OK with a stop at $55.50.
Near term at least. Borrow rate is north of 30%. No shares anywhere.
I bought some when you and Stoney were arguing its merits. Every single BROS's is packed. After crushing MULN, no problem using profits on a real stock like BROS.
It's a micro-cap out of Israel. Not many employees. Who does the R&D? Why no "careers" button on their website?
...Inquiring minds...
https://www.neurosense-tx.com/team/
That's probably the issue the Shorts have, when I saw a old friend was promoted to a CEO of a Nasdaq small biotech this weekend, made me wonder like you with NRSN. The last time this guy got a job, stock went from $.05 to $5 down to $.0001. I caught the pump because I knew how he operates after day trading ten years with him. If you can't trade, go run a concept bio? Thank you for your wisdom, always appreciate your b acumen
